Structural Heart Devices Market Size, Strategies and Segment Forecast to 2034
Global Structural Heart Devices Market Size- By Product, By Procedure, By End User -Regional Outlook, Competitive Strategies and Segment Forecast to 2034
| Published: Oct-2025 | Report ID: PHAR2536 | Pages: 1 - 244 | Formats*: |
| Category : Pharmaceutical | |||
Structural Heart Devices Market Introduction and Overview
According to SPER Market Research, Global Structural Heart Devices Market is estimated to reach USD 29.78 billion by 2034 with a CAGR of 9.06%.
The report includes an in-depth analysis of the Global Structural Heart Devices Market, including market size and trends, product mix, Applications, and supplier analysis. The Structural Heart Devices Market was valued at USD 12.51 billion in 2024, and it is expected to rise at a 9.06% CAGR from 2025 to 2034. Demand for structural heart devices is driven by the rising prevalence of structural heart diseases such as aortic stenosis and mitral regurgitation, particularly in aging populations. Advancements in minimally invasive technologies like TAVR and TMVR offer safer and more effective alternatives to open-heart surgery, increasing adoption. Growing awareness and improved early diagnosis of heart diseases are boosting demand for advanced therapies. Additionally, favourable reimbursement policies across several countries are supporting wider patient access, further fuelling market growth.
By Product Insights
The market is classified into heart valve devices, annuloplasty rings, occludes and delivery systems, and other products, with the heart valve devices segment generating the highest revenue. Conditions such as calcific aortic valve disease and rheumatic heart disease have a considerable healthcare impact worldwide. In the U.S., a significant share of the population suffers from heart valve disease, which is also responsible for thousands of deaths each year. These complications increase the need for efficient management and treatment, creating scope for greater utilization of heart valve devices. Furthermore, the market for advanced cardiovascular devices is supported by continuous improvements in heart valve technologies and non-invasive transcatheter replacement procedures, which are less invasive and more comfortable for patients, thereby driving market growth.
By Procedure Insights
The structural heart devices market is segmented into replacement procedures and repair procedures, with replacement procedures holding the leading share in 2024. The adoption of transcatheter heart valve replacement reflects a strong shift toward minimally invasive techniques, which are favoured by patients for their faster recovery times. Additionally, advancements in robotic-assisted heart surgery have transformed replacement approaches, allowing surgeons greater precision and control through robotic arms. Ongoing innovations in device design and procedural methods have further enhanced clinical outcomes, while key factors such as patient safety, shorter hospital stays, and improved quality of life continue to strengthen the prominence of replacement procedures in the market.
By End User Insights
The hospital segment dominated the structural heart devices market in 2024 and is expected to maintain its lead throughout the forecast period. Hospitals are equipped with advanced technologies such as transcatheter aortic valve replacement (TAVR) and transcatheter mitral valve repair (TMVR), which require specialized tools and skilled expertise. Facilities with dedicated cardiac care units and interventional cardiology departments are particularly capable of performing these procedures.
Regional Insights
North America held the largest share of the structural heart devices market in 2024, driven by the growing prevalence of cardiovascular diseases, rising cases of heart valve disorders, and supportive government initiatives that boost awareness and funding for prosthetic heart valve treatments. Furthermore, The structural heart devices market in Asia Pacific is anticipated to expand at the quickest rate during the forecast period. The market is growing due to increased elderly populations, an increase in CVD incidence, and technological advancements.
Market Competitive Landscape
The structural heart devices market is highly competitive, with numerous global and regional players striving to strengthen their market positions. Leading companies such as Abbott, Medtronic, Edwards Lifesciences, and Boston Scientific hold significant shares due to their strong portfolios of transcatheter and surgical heart valve technologies. To expand their reach and capabilities, these companies actively pursue strategies like mergers and acquisitions, partnerships, and facility expansions. Continuous investment in research and development allows them to innovate device designs, improve procedural outcomes, and incorporate advanced technologies. Smaller and emerging players also focus on niche therapies and regional expansion.
Recent Developments:
The FDA approved LUMA Vision's VERAFEYE product in April 2025, providing real-time 360° catheter navigation support for electrophysiology and structural cardiac treatments.
In November 2024, The U.S. Food and Drug Administration (FDA) granted De Novo authorization to Pi-Cardia for their unique Shortcut system. This innovative device addresses a serious coronary blockage problem and supports valve-in-valve Transcatheter Aortic Valve Replacement (TAVR) surgeries.
Scope of the report:
| Report Metric | Details |
| Market size available for years | 2021-2034 |
| Base year considered | 2024 |
| Forecast period | 2025-2034 |
| Segments covered | By Product, By Procedure, By End User |
| Regions covered | North America, Latin America, , Europe, and Middle East & Africa |
| Companies Covered | Abbott, AtriCure, BIOMERICS, Boston Scientific, BRAILE, CryoLife, Edwards, JENAVALVE, LEPU, MEDICAL, LivaNova, Medtronic, NUMED. |
Key Topics Covered in the Report
- Global Structural Heart Devices Market Size (FY’2021-FY’2034)
- Overview of Global Structural Heart Devices Market
- Segmentation of Global Structural Heart Devices Market by Product (Heart valve devices, valves Annuloplasty rings, Occludes and delivery systems)
- Segmentation Global Structural Heart Devices Market by Procedure (Replacement procedures, Repair procedures)
- Segmentation of Global Structural Heart Devices Market by End User (Hospitals Ambulatory surgical centres, Cardiac catheterization labs, Other end user)
- Statistical Snap of Global Structural Heart Devices Market
- Expansion Analysis of Global Structural Heart Devices Market
- Problems and Obstacles in Global Structural Heart Devices Market
- Competitive Landscape in the Global Structural Heart Devices Market
- Details on Current Investment in Global Structural Heart Devices Market
- Competitive Analysis of Global Structural Heart Devices Market
- Prominent Players in the Global Structural Heart Devices Market
- SWOT Analysis of Global Structural Heart Devices Market
- Global Structural Heart Devices Market Future Outlook and Projections (FY’2025-FY’2034)
- Recommendations from Analyst
1.Introduction
1.1.Scope of the report1.2.Market segment analysis
2.Research Methodology
2.1.Research data source2.1.1.Secondary Data2.1.2.Primary Data2.1.3.SPERs internal database2.1.4.Premium insight from KOLs2.2.Market size estimation2.2.1.Top-down and Bottom-up approach2.3.Data triangulation
3.Executive Summary
4.Market Dynamics
4.1.Driver, Restraint, Opportunity and Challenges analysis
4.1.1.Drivers4.1.2.Restraints4.1.3.Opportunities4.1.4.Challenges
5.Market variable and outlook
5.1.SWOT Analysis5.1.1.Strengths5.1.2.Weaknesses5.1.3.Opportunities5.1.4.Threats5.2.PESTEL Analysis5.2.1.Political Landscape5.2.2.Economic Landscape5.2.3.Social Landscape5.2.4.Technological Landscape5.2.5.Environmental Landscape5.2.6.Legal Landscape5.3.PORTERs Five Forces5.3.1.Bargaining power of suppliers5.3.2.Bargaining power of buyers5.3.3.Threat of Substitute5.3.4.Threat of new entrant5.3.5.Competitive rivalry5.4.Heat Map Analysis
6.Competitive Landscape
6.1.Global Structural Heart Devices Market Manufacturing Base Distribution, Sales Area, Product Type6.2.Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Structural Heart Devices Market
7.Global Structural Heart Devices Market, By Product (USD Million) 2021-2034
7.1.Heart valve devices7.1.1.Surgical heart valves7.1.2.Transcatheter heart valves7.2. Annuloplasty rings7.3.Occluders and delivery systems7.4.Other products
8.Global Structural Heart Devices Market, By Procedure (USD Million) 2021-2034
8.1.Replacement procedures8.1.1.Replacement procedures8.1.2.Surgical aortic valve replacement (SAVR)8.1.3.Transcatheter aortic valve replacement (TAVR)8.1.4.Transcatheter mitral valve replacement (TMVR)8.1.5.Other replacement procedures8.2.Repair procedures8.2.1.Left atrial appendage closure (LAAC)8.2.2.Transcatheter mitral valve repair (TMVr)8.2.3.Transcatheter tricuspid valve repair (TTVr)8.2.4.Valvuloplasty8.2.5.Other repair procedures
9.Global Structural Heart Devices Market, By End User (USD Million) 2021-2034
9.1.Hospitals9.2.Ambulatory surgical centres9.3.Cardiac catheterization labs9.4.Other end user
10.Global Structural Heart Devices Market, (USD Million) 2021-2034
10.1.Global Structural Heart Devices Market Size and Market Share
11.Global Structural Heart Devices Market, By Region, (USD Million) 2021-2034
11.1.Asia-Pacific11.1.1.Australia11.1.2.China11.1.3.India11.1.4.Japan11.1.5.South Korea11.1.6.Rest of Asia-Pacific11.2.Europe11.2.1.France11.2.2.Germany11.2.3.Italy11.2.4.Spain11.2.5.United Kingdom11.2.6.Rest of Europe11.3.Middle East and Africa11.3.1.Kingdom of Saudi Arabia11.3.2.United Arab Emirates11.3.3.Qatar11.3.4.South Africa11.3.5.Egypt11.3.6.Morocco11.3.7.Nigeria11.3.8.Rest of Middle-East and Africa11.4.North America11.4.1.Canada11.4.2.Mexico11.4.3.United States11.5.Latin America11.5.1.Argentina11.5.2.Brazil11.5.3.Rest of Latin America
12.Company Profile
12.1.Abbott12.1.1.Company details12.1.2.Financial outlook12.1.3.Product summary12.1.4.Recent developments12.2.AtriCure12.2.1.Company details12.2.2.Financial outlook12.2.3.Product summary12.2.4.Recent developments12.3.BIOMERICS12.3.1.Company details12.3.2.Financial outlook12.3.3.Product summary12.3.4.Recent developments12.4.Boston Scientific12.4.1.Company details12.4.2.Financial outlook12.4.3.Product summary12.4.4.Recent developments12.5.BRAILE12.5.1.Company details12.5.2.Financial outlook12.5.3.Product summary12.5.4.Recent developments12.6.CryoLife12.6.1.Company details12.6.2.Financial outlook12.6.3.Product summary12.6.4.Recent developments12.7.Edwards12.7.1.Company details12.7.2.Financial outlook12.7.3.Product summary12.7.4.Recent developments12.8.JENAVALVE12.8.1.Company details12.8.2.Financial outlook12.8.3.Product summary12.8.4.Recent developments12.9.LEPU MEDICAL12.9.1.Company details12.9.2.Financial outlook12.9.3.Product summary12.9.4.Recent developments12.10.LivaNova12.10.1.Company details12.10.2.Financial outlook12.10.3.Product summary12.10.4.Recent developments12.11.Medtronic12.11.1.Company details12.11.2.Financial outlook12.11.3.Product summary12.11.4.Recent developments12.12.NUMED12.12.1.Company details12.12.2.Financial outlook12.12.3.Product summary12.12.4.Recent developments12.13.Others
13.Conclusion
14.List of Abbreviations
15.Reference Links
SPER Market Research’s methodology uses great emphasis on primary research to ensure that the market intelligence insights are up to date, reliable and accurate. Primary interviews are done with players involved in each phase of a supply chain to analyze the market forecasting. The secondary research method is used to help you fully understand how the future markets and the spending patterns look likes.
The report is based on in-depth qualitative and quantitative analysis of the Product Market. The quantitative analysis involves the application of various projection and sampling techniques. The qualitative analysis involves primary interviews, surveys, and vendor briefings. The data gathered as a result of these processes are validated through experts opinion. Our research methodology entails an ideal mixture of primary and secondary initiatives.
Frequently Asked Questions About This Report
Structural Heart Devices Market is projected to reach USD 29.78 by 2034, growing at a CAGR of 9.06% during the forecast period.
Structural Heart Devices Market size from 2025. The Market is expected to reach USD 29.78 by 2034, at a CAGR of 9.06% during the forecast period.
Structural Heart Devices Market CAGR of 9.06% during the forecast period.
You can get the sample pages by clicking the link - Click Here
Structural Heart Devices Market size is USD 29.78 from 2025 to 2034.
Structural Heart Devices Market covered By Product, By Procedure, By End User
The North America is anticipated to have the highest Market share in the Structural Heart Devices Market .
"Abbott, AtriCure, BIOMERICS, Boston Scientific, BRAILE, CryoLife, Edwards, JENAVALVE, LEPU, MEDICAL, LivaNova, Medtronic, NUMED.
"
The report includes an in-depth analysis of the Global Structural Heart Devices Market, including market size and trends, product mix, Applications, and supplier analysis
PLACE AN ORDER
Year End Discount
Sample Report
Pre-Purchase Inquiry
NEED CUSTOMIZATION?
Request CustomizationCALL OR EMAIL US
100% Secure Payment
Related Reports
Have a glance of the Report
Our Global Clients
Our data-driven insights have influenced the strategy of 200+ reputed companies across the globe.
